Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03379545 · ClinicalTrials.gov registry record · NA
3D MR Versus 3D CT for Glenohumeral Arthritis
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT03379545 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 31 participants.
The verdict
NCT03379545, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
This study aims to assess the efficacy of three-dimensional magnetic resonance (MR) compared to three-dimensional computed tomography (CT) imaging. This proposed study is a prospective, unrandomized, single-blinded, self-controlled, and single-armed diagnostic radiological evaluation study.
Interventions
- DIAGNOSTIC_TEST 3-dimensional (3D) magnetic resonance (MR) imaging
- DIAGNOSTIC_TEST 3D computed tomography (CT) imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2017-01-11 |
| Est. Completion | 2020-06-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03379545
The ClinicalTrials.gov registry entry for NCT03379545 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 3-dimensional (3D) magnetic resonance (MR) imaging is the first listed.
NCT03379545 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03379545 about?
NCT03379545 is a clinical study titled "3D MR Versus 3D CT for Glenohumeral Arthritis". This study aims to assess the efficacy of three-dimensional magnetic resonance (MR) compared to three-dimensional computed tomography (CT) imaging. This proposed study is a prospective, unrandomized, single-blinded, self-controlled, and single-armed diagnostic radiological evaluation study.
What is the current status of trial NCT03379545?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2017-01-11. Estimated completion is 2020-06-05.
What interventions are being tested in trial NCT03379545?
The interventions under investigation include: 3-dimensional (3D) magnetic resonance (MR) imaging (DIAGNOSTIC_TEST), 3D computed tomography (CT) imaging (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03379545?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.